Clinical trialNCT04585958RecruitingPhase 1Interventional

Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

SponsorNational Cancer Institute (NCI)Enrollment55Metastatic Malignant Solid NeoplasmPlatinum-Resistant Ovarian High Grade Serous AdenocarcinomaUnresectable Malignant Solid Neoplasm

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Elizabeth K Lee
Dana-Farber - Harvard Cancer Center LAO
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
Active, not recruiting
Mayo Clinic in Florida
Jacksonville, Florida, United States
Andrea E. Wahner Hendrickson
Recruiting
Emory University Hospital Midtown
Atlanta, Georgia, United States
Kristen Starbuck
Recruiting
Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
Kristen Starbuck
Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Elizabeth K. Lee
Recruiting
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Andrea E. Wahner Hendrickson
Recruiting
University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
Sarah E. Taylor
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 21 May 2021
Primary completion: 31 Dec 2026
Completion: 31 Dec 2026
Last update posted: 5 Jun 2026
Registered enrollment: 55
Registry id: NCT04585958

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.